R68070, a combined thromboxane/endoperoxide receptor antagonist and thromboxane synthase inhibitor, inhibits human platelet activation in vitro and in vivo: a comparison with aspirin.

MLA

Hoet, B., et al. “R68070, a Combined Thromboxane/Endoperoxide Receptor Antagonist and Thromboxane Synthase Inhibitor, Inhibits Human Platelet Activation in Vitro and in Vivo: A Comparison with Aspirin.” Blood, vol. 75, no. 3, Feb. 1990, pp. 646–53. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=2153424&authtype=sso&custid=ns315887.

APA

Hoet, B., Falcon, C., De Reys, S., Arnout, J., Deckmyn, H., & Vermylen, J. (1990). R68070, a combined thromboxane/endoperoxide receptor antagonist and thromboxane synthase inhibitor, inhibits human platelet activation in vitro and in vivo: a comparison with aspirin. Blood, 75(3), 646–653.

Chicago

Hoet, B, C Falcon, S De Reys, J Arnout, H Deckmyn, and J Vermylen. 1990. “R68070, a Combined Thromboxane/Endoperoxide Receptor Antagonist and Thromboxane Synthase Inhibitor, Inhibits Human Platelet Activation in Vitro and in Vivo: A Comparison with Aspirin.” Blood 75 (3): 646–53. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=2153424&authtype=sso&custid=ns315887.